Hjem › Sigdcelleanemi › California
Kliniske studier for Sigdcelleanemi i California
18 studier for Sigdcelleanemi søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
Exercise in Child Health
- University of California, Irvine, Irvine
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 10 til 17 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05359991A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Ctr for Inherited Blood Disorders, Orange
RekruttererFase 3
Alder 12 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06439082A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Children's Hospital Los Angeles - Endocrinology, Los Angeles
- UCSF Oakland Benioff ChildHosp, Oakland
RekruttererFase 3
Alder 2 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Children's Hospital Los Angeles - Endocrinology, Los Angeles
- Valley Children's Hospital, Madera
- Stanford University_Palo Alto, Palo Alto
- og 1 flere
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06612268Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
- Harbor UCLA Medical Center, Torrance
RekruttererFase 2
Alder 5 til 20 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07369024A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- University of California San Diego - La Jolla, La Jolla
- UCSF Benioff Children's Hospital Oakland, Oakland
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Orthopaedic Institute for Children HTC, Los Angeles
- Childrens Hospital Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital Oakland, Oakland
- og 5 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Univ. of California, San Francisco Health Care, Oakland
- University of California Irvine, Orange
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- University of California Irvine, Orange
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of California San Francisco- Site Number : 8400040, Fresno
RekruttererFase 3
Alder 10 til 65 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- University of California Los Angeles, Los Angeles
RekruttererFase 2
6 Months – 21 Years · Alle kjønn · Oppdatert 27. jul. 2026 · NCT02675959Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
- UC Davis Comprehensive Cancer Center, Sacramento
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 16. jul. 2026 · NCT06016634Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Children's Hospital Los Angeles, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
RekruttererFase 1/2
Alder 12 til 50 · Alle kjønn · Oppdatert 2. jul. 2026 · NCT04819841Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
- City of Hope Medical Center, Duarte
RekruttererFase 1
Alder 1 til 30 · Alle kjønn · Oppdatert 12. mai 2026 · NCT03279094Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
- University of California, Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital, Oakland
RekruttererFase 1/2
Alder 12 til 35 · Alle kjønn · Oppdatert 16. apr. 2026 · NCT04774536Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- UCSF Benioff Children's Hospital Oakland, Oakland
RekruttererFase 2
Alder 15 til 40 · Alle kjønn · Oppdatert 13. mar. 2026 · NCT06260891Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- UCLA Mattel Children's Hospital Ronald Reagan Hospital, Los Angeles
Rekrutterer
Alder 16 til 30 · Alle kjønn · Oppdatert 7. jan. 2026 · NCT06374238Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of California, San Francisco (UCSF), Oakland
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2025 · NCT06385886Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.